Skip to main content

TOCQUEVILLE ASSET MANAGEMENT L.P.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 883961 New York, NY

Position in BBIO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,397,944
-$38,155 QoQ
Shares Held
18,825
+0.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Mar 31, 2026
CallValue
$74,260
CallShares
1,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TOCQUEVILLE ASSET MANAGEMENT L.P. holds $35,568,620 across 14 Biotechnology names. BBIO ranks #4 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 BBIO
BridgeBio Pharma, Inc.
This page
18,825 $1,397,944

All Filings in BBIO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,397,944 18,825
2026-03-31 $74,260 1,000
2025-12-31 $1,436,099 18,775
2025-12-31 $76,490 1,000
2025-09-30 $975,173 18,775
2025-06-30 $809,625 18,750
2025-03-31 $658,558 19,050
2024-12-31 $520,674 18,975
2024-09-30 $450,642 17,700
2024-06-30 $385,016 15,200
2024-03-31 $392,684 12,700
2023-12-31 $540,958 13,400
2023-09-30 $374,454 14,200
2023-06-30 $331,100 19,250
2023-03-31 $365,589 22,050